Herceptin, Trastuzumab Newswire (Page 2)

Herceptin, Trastuzumab Newswire (Page 2)

Comprehensive Real-Time News Feed for Herceptin, Trastuzumab (generic). (Page 2)

Results 21 - 40 of 635 in Herceptin, Trastuzumab (generic)

  1. Mentally ill still gain illegal possession of gunsRead the original story w/Photo

    Wednesday Jun 8 | CBS 3 Springfield

    Almost two-thirds of violent gun crime arrests among the mentally ill were people who were already legally prohibited from having a firearm, a new study from Florida reveals. Almost two-thirds of violent gun crime arrests among the mentally ill were people who were already legally prohibited from having a firearm, a new study from Florida reveals.

    Comment?

  2. Breast Cancer Drugs Market 2016-2026: Revenue Forecasts for...Read the original story w/Photo

    Tuesday Jun 7 | PR Newswire

    Breast Cancer Therapies - Discover From 2016 What Revenues Are Possible Are you interested in the breast cancer drug market's future? If so, you find that sales forecasting from 2016 in our new report. See there what is possible for those products and companies.

    Comment?

  3. Cheaper breast cancer drug does well in clinical trialRead the original story w/Photo

    Tuesday Jun 7 | KFVS12

    For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. HER2-positive tumors contain certain genes that are associated with more rapid tumor growth and a worse prognosis, according to the American Cancer Society.

    Comment?

  4. Drug duo cures a tick-borne disease -- in miceRead the original story w/Photo

    Tuesday Jun 7 | CBS 3 Springfield

    For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. Certain vaccines can trigger fever-related seizures in young children, but the risk is so low that pediatricians might see one case every five to 10 years, a new study estimates.

    Comment?

  5. Childhood vaccinations rarely spur seizuresRead the original story w/Photo

    Tuesday Jun 7 | CBS 3 Springfield

    For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds.

    Comment?

  6. Oncobiologics Inc (ONSIU) Coverage Initiated at BarclaysRead the original story w/Photo

    Tuesday Jun 7 | AmericanBankingNews.com

    The firm set an "overweight" rating and a $11.00 price target on the stock. Barclays' price target would suggest a potential upside of 115.26% from the company's previous close.

    Comment?

  7. Cantor Fitzgerald Begins Coverage on Oncobiologics IncRead the original story w/Photo

    Tuesday Jun 7 | AmericanBankingNews.com

    The firm set a "buy" rating and a $15.00 price target on the stock. Cantor Fitzgerald's target price would suggest a potential upside of 193.54% from the stock's current price.

    Comment?

  8. Oncobiologics Inc (ONSIU) Coverage Initiated at BarclaysRead the original story w/Photo

    Tuesday Jun 7 | AmericanBankingNews.com

    The firm set an "overweight" rating and a $11.00 price target on the stock. Barclays' price target suggests a potential upside of 115.26% from the stock's previous close.

    Comment?

  9. U.S. Pays Highest Prices for Cancer Meds: StudyRead the original story w/Photo

    Monday Jun 6 | MedicineNet

    The United States pays the highest prices in the world for generic and brand-name cancer drugs , a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein.

    Comment?

  10. Cheaper Breast Cancer Drug Does Well in Clinical TrialRead the original story w/Photo

    Monday Jun 6 | MedicineNet

    For women with advanced HER2-positive breast cancer , a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. HER2-positive tumors contain certain genes that are associated with more rapid tumor growth and a worse prognosis, according to the American Cancer Society.

    Comment?

  11. Biosimilars: Still Not Quite Ready for Prime TimeRead the original story

    Monday Jun 6 | P&T Community

    The United States is the largest biologics market in the world and has the highest prices for biologics, which include monoclonal antibodies, therapeutic proteins, immunomodulators, and growth factors. Unlike traditional chemical drugs, most biologics are not distributed via traditional distribution channels but instead are considered "specialty" drugs, which are supplied via specialty pharmacy distribution services.

    Comment?

  12. U.S. pays highest prices for cancer drugs, study saysRead the original story w/Photo

    Monday Jun 6 | NOLA.com

    In this Tuesday, Aug. 4, 2015 file photo, a nurse places a patient's chemotherapy medication on an intravenous stand at a hospital in Philadelphia. A report released on Thursday, Jan. 7, 2016 says cancer is the second leading cause of death nationally, after heart disease.

    Comment?

  13. Breast Cancer Survivors Need Heart MonitoringRead the original story w/Photo

    Monday Jun 6 | News Max

    With more breast cancer patients surviving years after their treatment, there is growing concern their hearts may not be getting adequate care, a new study finds. Thanks to developments in chemotherapy, 87 percent of breast cancer patients are surviving five years or more.

    Comment?

  14. c-Jun N-terminal kinase activation has a prognostic implication and...Read the original story w/Photo

    Sunday Jun 5 | BioMed Central

    Since the biological function of c-Jun N-terminal kinase in gastric cancer remains unclear, we investigated the clinical significance of JNK activation and its association with FOXO1 activation. Immunohistochemical tissue array analysis of 483 human gastric cancer specimens was performed, and the results of the immunostaining were quantified.

    Comment?

  15. ASCO2016: Oncothyreon Presents Phase Ib Results Of ONT-380 In...Read the original story

    Sunday Jun 5 | BioSpace

    Oncothyreon Inc. , a clinical-stage biopharmaceutical company, today announced the presentation of clinical data on its lead product candidate, ONT-380, at the 52nd Annual Meeting of the American Society of Clinical Oncology . ONT-380 is a highly selective small molecule HER2 inhibitor being developed in combination to treat HER2+ advanced or metastatic breast cancer.

    Comment?

  16. US Pays Highest Cost for Cancer MedsRead the original story w/Photo

    Monday Jun 6 | News Max

    The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein.

    Comment?

  17. ASCO2016: Mylan-BioCon''s Biosimilar Cancer Drug Comparable to Roche's HerceptinRead the original story

    Sunday Jun 5 | BioSpace

    Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology Annual Meeting - HERITAGE Study Shows Comparable Efficacy, Safety and Immunogenicity to Branded Trastuzumab in HER2-Positive Metastatic Breast Cancer Patients /PRNewswire/ -- Mylan N.V. and Biocon Ltd. today announced the presentation of data from the HERITAGE study at the 2016 American Society of Clinical Oncology Annual Meeting in . The study confirmed the efficacy, safety and immunogenicity of MYL-1401O, the proposed biosimilar trastuzumab co-developed by Biocon and Mylan, in comparison to branded trastuzumab.

    Comment?

  18. Cheaper Breast Cancer Drug Shows PromiseRead the original story w/Photo

    Friday Jun 3 | WebMD

    FRIDAY, June 3, 2016 -- For women with advanced HER2 -positive breast cancer , a similar but less expensive experimental drug works just as well as the standard drug Herceptin , a new study finds. HER2-positive tumors contain certain genes that are associated with more rapid tumor growth and a worse prognosis, according to the American Cancer Society.

    Comment?

  19. New study: Cheaper version of Herceptin found to be just as effectiveRead the original story w/Photo

    Sunday Jun 5 | Bay Area Business Woman

    HER2-positive breast cancer which usually has a more aggressive tumor growth due to the genes located in the tissue. annual meeting of the American Society of Clinical Oncology.

    Comment?

  20. Study Suggests Action Required to Minimise Heart Failure in Breast Cancer SurvivorsRead the original story

    Sunday Jun 5 | Newswise

    Despite the known toxic effects of chemotherapy on the heart, the majority of women undergoing breast cancer treatment are not getting the recommended follow-up heart scans, according to research presented at the British Cardiovascular Society Conference in Manchester today . The research was carried out at the University of Dundee and funded by the Grant Simpson Trust and the Tayside Oncology Research Endowment Fund.

    Comment?